Magellan Biosciences
Chelmsford, MA 01824
Magellan Biosciences Companies to Feature New Automated Products at the American Society of Microbiology Meeting, Booth 113
CHELMSFORD, Mass., May 16 - Magellan Biosciences, an emerging leader in clinical-diagnostics markets worldwide, will feature new automated systems designed to improve outcomes for busy microbiology labs at the American Society of Microbiology (ASM) meeting in Toronto, Canada. Magellan subsidiary, TREK Diagnostic Systems, will share booth 113 with sister company, Dynex Technologies, at the...
Read More »Magellan Biosciences Announces Agreement with Bruker to Provide Microbiology Tools to Battle Drug Resistance
CHELMSFORD, Mass., April 13, 2011 - Magellan Biosciences, a global manufacturer of products designed to make diagnostic testing easier, more cost-effective, and less labor intensive, today announced an agreement with Bruker Corporation (NASDAQ: BRKR) to deliver microbial identification from cultures using MALDI-TOF proteomic finger-printing, along with Magellan's TREK-brand susceptibility tests...
Read More »Magellan Biosciences Companies to Feature New Automated Products at the American Society of Microbiology Meeting, Booth 113
CHELMSFORD, Mass., May 16 - Magellan Biosciences, an emerging leader in clinical-diagnostics markets worldwide, will feature new automated systems designed to improve outcomes for busy microbiology labs at the American Society of Microbiology (ASM) meeting in Toronto, Canada. Magellan subsidiary, TREK Diagnostic Systems, will share booth 113 with sister company, Dynex Technologies, at the...
Read More »